Estimated antiretroviral therapy coverage among people living with HIV in AFR
AFR: Estimated antiretroviral therapy coverage among people living with HIV was 83.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in AFR, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
AFR recorded 83.0% for estimated antiretroviral therapy coverage among people living with hiv in 2025. That is the highest value across all 26 years on record.
Compared with earlier readings it is up 1.2% on the previous year and up 69.4% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in AFR peaked at 83.0% in 2025 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in AFR, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 1.0% | — |
| 2004 | 2.0% | +100.0% |
| 2005 | 4.0% | +100.0% |
| 2006 | 6.0% | +50.0% |
| 2007 | 10.0% | +66.7% |
| 2008 | 14.0% | +40.0% |
| 2009 | 18.0% | +28.6% |
| 2010 | 23.0% | +27.8% |
| 2011 | 28.0% | +21.7% |
| 2012 | 34.0% | +21.4% |
| 2013 | 39.0% | +14.7% |
| 2014 | 44.0% | +12.8% |
| 2015 | 49.0% | +11.4% |
| 2016 | 55.0% | +12.2% |
| 2017 | 60.0% | +9.1% |
| 2018 | 64.0% | +6.7% |
| 2019 | 68.0% | +6.2% |
| 2020 | 72.0% | +5.9% |
| 2021 | 74.0% | +2.8% |
| 2022 | 77.0% | +4.1% |
| 2023 | 80.0% | +3.9% |
| 2024 | 82.0% | +2.5% |
| 2025 | 83.0% | +1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.5% | 0.0% | 18.0% | 10 |
| 2010s | 46.4% | 23.0% | 68.0% | 10 |
| 2020s | 78.0% | 72.0% | 83.0% | 6 |
Countries ranked near AFR
- 1 Botswana 98.0% compare
- 2 Saudi Arabia 97.0% compare
- 2 Sao Tome and Principe 97.0% compare
- 4 Lesotho 96.0% compare
More health data for AFR
- Mortality rate among children ages 5 to 9 years 8.27 (2024)
- Population with primary reliance on polluting fuels and technologies 632.45 (2023)
- Population with primary reliance on fuels and technologies for 572.82 (2023)
- Proportion of population with primary reliance on fuels and 83.2% (2023)
- Prevalence of diabetes, crude 8.58 (2022)
- Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 83.0% (2025)
- Measles-containing-vaccine first-dose (MCV1) immunization coverage 71.0% (2025)
- New HIV infections 0.49 (2025)
- BCG immunization coverage among 1-year-olds (%) 82.0% (2025)
- Mean total cholesterol, crude 4 (2018)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in AFR?
- Estimated antiretroviral therapy coverage among people living with hiv in AFR was 83.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in AFR?
- The highest recorded value was 83.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in AFR?
- The lowest recorded value was 0.0% in 2000.
- How does AFR rank for estimated antiretroviral therapy coverage among people living with hiv?
- AFR ranks 1st out of 13 groups with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in AFR?
- Over the last ten years it is up 69.4%. The long-run trend across the full record is volatile.
- Where does this AFR data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).